Jaguar Health, Inc.
JAGX
$10.91
-$0.83-7.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.80% | 4.96% | 19.77% | 8.03% | 12.97% |
| Total Depreciation and Amortization | -1.26% | -1.79% | 1.02% | 2.47% | 4.19% |
| Total Amortization of Deferred Charges | -97.93% | -86.28% | -8.41% | 27.06% | 12.32% |
| Total Other Non-Cash Items | 166.24% | 1,181.66% | 70.58% | 216.69% | -24.64% |
| Change in Net Operating Assets | 72.88% | 51.45% | -117.82% | -56.69% | -150.65% |
| Cash from Operations | 11.61% | 9.95% | 13.24% | 14.17% | -0.42% |
| Capital Expenditure | -- | -- | -433.33% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 95.57% | 96.16% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 25.71% | 16.94% | 35.29% | -16.97% | 24.12% |
| Issuance of Common Stock | -0.85% | 56.88% | 23.71% | -7.82% | 57.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -107.09% | 1.16% | -0.66% | -28.60% | 2,250.49% |
| Cash from Financing | -8.84% | 54.76% | 8.68% | -18.20% | 47.65% |
| Foreign Exchange rate Adjustments | -460.00% | 84.00% | -116.67% | -136.73% | -6.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.30% | 236.92% | 2,017.83% | 12.72% | 108.63% |